Ge healthcare announces new innovations and collaborations in image guided therapy as part of tct2023 cardiology care pathway showcase

San francisco--(business wire)--ge healthcare (nasdaq: gehc) will showcase some of the latest innovations designed to help clinicians in the treatment of cardiovascular disease at the 2023 transcatheter cardiovascular therapeutics conference (tct) which will take place october 23-26 in san francisco, ca. in modern healthcare today, cardiovascular disease (cvd) continues to grow in prevalence, with cvds continuing to be the leading cause of death globally.1 as clinicians work to treat cvd, cardi.
GEHC Ratings Summary
GEHC Quant Ranking